Agency Prescription Skincare: Honest Pricing, What It Prescribes, and Whether It Makes Sense for Your Life Stage

What Is Agency and How Does Its Business Model Work?

Agency is a prescription skincare telehealth platform that operates on a direct-to-consumer subscription model. You complete an online intake, upload photos of your skin, a licensed clinician reviews your case asynchronously, and a compounded topical formula is shipped to your door. The brand positions itself in the same market space that Curology pioneered, though Agency has since differentiated itself with a slightly broader ingredient menu and a focus on what it calls "skin longevity."

The clinically meaningful piece here is the word "compounded." Agency does not dispense FDA-approved finished drug products. Its formulas are prepared by compounding pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act, which means each preparation is made for an individual patient prescription rather than manufactured at scale. Section 503A compounding is legal and common, but it also means the final product is not subject to the same pre-market efficacy and manufacturing-consistency review as a commercially approved drug.

That distinction matters when you are comparing price. A tube of Tretinoin 0.025% cream from a retail pharmacy with a GoodRx coupon can cost $12 to $25. Agency bundles the clinical consultation, the custom combination formula, and the shipping into a single subscription fee.

Who Owns and Operates Agency?

Agency emerged from the broader system of venture-backed telehealth skincare brands. Its clinical model uses licensed dermatology providers or clinicians working under dermatology supervision, depending on the state. For women reading this: your prescribing clinician may be a nurse practitioner, physician assistant, or dermatologist, and state law governs exactly who can prescribe what. Ask when you sign up.

Agency Pricing: The Real Numbers

Agency's pricing is not fully transparent at first glance, which is a common complaint in online reviews. Here is what the structure actually looks like based on publicly available subscription information.

Introductory and Ongoing Monthly Costs

Agency frequently offers a first-month trial at a reduced rate, often around $10 to $20, before transitioning to a standard subscription. Ongoing monthly costs depend on formulation complexity:

• Base formula (tretinoin + one or two actives): approximately $35 to $50 per month
• Multi-active formula (e.g., tretinoin + azelaic acid + tranexamic acid or clindamycin): approximately $55 to $90 per month
• Add-ons (SPF moisturizer, cleanser): $10 to $25 each per month

Annual cost at the mid-tier lands between $540 and $780 before any add-ons. That is meaningfully more than a pharmacy-dispensed tretinoin prescription alone, but it includes asynchronous clinical oversight, formula adjustment messages, and the convenience of a single shipment.

What You Are Actually Paying For

Breaking the fee into components helps you decide if it is worth it for your situation:

| Cost Component | Approximate Value | What You Get | |---|---|---| | Clinician consultation | $50 to $150 stand-alone telehealth visit | Async review + prescription | | Compounded formula | $15 to $40 ingredient cost estimate | Custom blend, no splitting of tubes | | Ongoing messaging | Included | Formula adjustments | | Shipping | Included | Monthly delivery |

The bundled model has genuine value if you do not have dermatology access, your insurance does not cover tretinoin (many plans categorize it as cosmetic), or you want a combination formula that would require multiple separate prescriptions elsewhere.

Hidden Costs to Watch

Cancellation timing matters. Several user reviews note that Agency's billing cycle renews before the next shipment ships, so canceling late in a cycle may still trigger a charge. Read the cancellation policy before your trial period ends.

What Agency Prescribes: The Ingredient Evidence

Tretinoin (All-Trans Retinoic Acid)

Tretinoin is the most clinically validated topical retinoid available. In a landmark 48-week randomized controlled trial published in NEJM, topical tretinoin 0.1% produced statistically significant improvements in fine wrinkles, mottled hyperpigmentation, and skin roughness compared with vehicle. Concentrations in Agency formulas typically range from 0.025% to 0.1%, which aligns with the evidence base.

For women with hormonal acne, the mechanism is directly relevant. Tretinoin normalizes follicular keratinization, the process by which dead skin cells clump inside the follicle and create the microcomedones that precede both inflammatory and non-inflammatory acne lesions. Sebaceous gland activity is androgen-driven, which is why hormonal acne in women with PCOS, the perimenstrual flare many women experience, and the new-onset adult acne that emerges in perimenopause all respond differently to topical-only regimens. If your acne is primarily hormonal in origin, tretinoin addresses the follicular piece but not the upstream androgen signal.

Azelaic Acid

Azelaic acid is a dicarboxylic acid with antimicrobial, anti-inflammatory, and tyrosinase-inhibiting properties. At 15% to 20% concentration, it is FDA-approved for both acne and rosacea. A Cochrane-reviewed analysis found azelaic acid was effective for acne with a favorable tolerability profile. Critically for women, azelaic acid is considered compatible with pregnancy, making it one of the few actives that can continue across a conception attempt or into the first trimester if a dermatologist advises it, though you should always confirm with your own prescriber.

Tranexamic Acid

Tranexamic acid (TXA) in topical form is increasingly used for melasma and post-inflammatory hyperpigmentation. Unlike oral TXA (which carries thrombotic risk and is used in surgical contexts), topical TXA at 2% to 5% concentrations has a localized action. A 2020 randomized trial in the Journal of the American Academy of Dermatology found topical TXA significantly reduced melasma area and severity index scores compared with vehicle. Melasma is overwhelmingly more common in women than men, triggered by estrogen, UV exposure, and hormonal fluctuation, which means it is an especially relevant ingredient for women using hormonal contraception, those who developed chloasma during pregnancy, and perimenopausal women on hormone therapy.

Niacinamide and Clindamycin

Niacinamide (vitamin B3) at 4% to 5% reduces sebum excretion and has anti-inflammatory effects. A double-blind trial comparing 4% niacinamide gel with 1% clindamycin gel found comparable efficacy for inflammatory acne with fewer side effects. Clindamycin is an antibiotic; its use in compounded formulas raises the standard concern about antibiotic resistance with prolonged topical use, a concern the American Academy of Dermatology addresses in its acne guidelines by recommending combination with benzoyl peroxide to reduce resistance risk. Agency formulas do not always include benzoyl peroxide, so ask your assigned clinician about this if clindamycin is in your formula.

How Hormonal Status Changes What Your Skin Needs

This is the section most prescription skincare brands skip. It matters.

Reproductive Years and Cyclic Hormonal Acne

Estrogen and progesterone shift across the menstrual cycle, and so does skin. In the luteal phase (roughly days 15 to 28 of a 28-day cycle), progesterone rises and sebum production increases. Research published in Acta Dermato-Venereologica documented that acne flares track with the luteal phase in a significant proportion of women with adult acne. Tretinoin can reduce baseline comedone burden, but it will not fully suppress a cyclically driven hormonal flare. If your acne consistently appears in the week before your period, a conversation about spironolactone or combined oral contraceptives as an adjunct is worth having, whether with Agency's clinicians or your own gynecologist.

PCOS-Related Acne

Women with polycystic ovary syndrome have elevated androgens that chronically upregulate sebaceous gland activity. The Endocrine Society's PCOS guideline notes that acne in PCOS often responds better to anti-androgen therapy (spironolactone, OCPs containing anti-androgenic progestins) than to topical treatments alone. Tretinoin is a useful adjunct, not a standalone solution, for PCOS-related acne. Agency's scope is limited to topical prescribing, so if PCOS is the root cause, you need a concurrent conversation about systemic management.

Perimenopause Skin Changes

Perimenopause (typically age 40 to 51) brings declining estrogen, which reduces skin collagen by approximately 30% in the first five years after menopause, thins the dermis, and increases transepidermal water loss. Tretinoin addresses photoaging and stimulates collagen synthesis, which is directly relevant here. Perimenopausal women may also notice new or worsened acne driven by the relative androgen excess that occurs as estrogen falls. This is where Agency's model can genuinely add value: a tretinoin-plus-azelaic acid formula addresses both the collagen-loss side and the pigmentation side simultaneously.

Postmenopausal Skin

Skin in postmenopause continues to thin. Tretinoin remains the most evidence-supported topical for collagen stimulation at this stage. Women on systemic hormone therapy may find their skin responds better to topicals because estrogen itself improves skin thickness and hydration. A randomized trial in Menopause found estrogen therapy improved skin hydration and elasticity scores compared with placebo. Agency does not prescribe hormone therapy, so its value here is complementary to, not a replacement for, that conversation with your gynecologist or menopause specialist.

Pregnancy, Lactation, and Contraception: Required Reading Before You Subscribe

If you are pregnant or actively trying to conceive, do not start a tretinoin-containing formula without reading this section carefully.

Tretinoin in Pregnancy: Category X

Systemic retinoids (isotretinoin, acitretin) are well-established human teratogens. Topical tretinoin has lower systemic absorption than oral retinoids, with most studies finding serum levels near or below the limit of quantification after topical application. However, the FDA labels topical tretinoin as Pregnancy Category C, and most clinical guidelines take a conservative stance: avoid topical tretinoin during pregnancy, particularly the first trimester, because the teratogenic mechanism of retinoids is well-established and the benefit does not outweigh the theoretical risk. Some compounding pharmacies and telehealth platforms do not prominently surface this warning. Agency should screen for pregnancy at intake; if yours did not ask, that is a red flag.

If you are using a tretinoin formula, you should use reliable contraception. This is the same recommendation made for any retinoid-containing prescription. ACOG recommends that clinicians discuss contraception when prescribing any medication with fetal risk, even topical retinoids. ACOG Practice Bulletin on contraception counseling is the standard framework for that conversation.

Lactation

Topical tretinoin is not significantly absorbed systemically in most studies, so the theoretical transfer into breast milk is low. Still, the standard clinical recommendation is to avoid tretinoin while breastfeeding given the lack of controlled human lactation data. LactMed, the NIH drug and lactation database, lists topical retinoids as "probably compatible" with breastfeeding given low systemic absorption but notes data are limited and caution is reasonable.

What You Can Use Safely Across the Reproductive Lifespan

• Azelaic acid 15-20%: generally considered safe in pregnancy and lactation; classified as Pregnancy Category B
• Niacinamide: no teratogenicity signal; considered safe topically
• Clindamycin topical: classified Category B; used for acne in pregnancy by many dermatologists
• Tretinoin: avoid in pregnancy and during unprotected conception attempts; use caution in lactation

If you are postpartum and breastfeeding and want to restart your formula, tell Agency's clinician explicitly. The formula should be adjusted to remove tretinoin until you wean.

A Life-Stage Decision Framework: Is Agency Right for You?

Rather than a single "yes or no" answer, here is a practical framework by life stage.

Reproductive Years, Not Trying to Conceive

This is Agency's strongest use case. You have reliable contraception, you want tretinoin-based treatment for hormonal acne or early photoaging, and you prefer the convenience of a subscription over booking a dermatology appointment with a 4-to-6-month wait. The cost is reasonable if you value bundled convenience. If your primary driver is hormonal acne, ask the clinician whether a systemic option (spironolactone, OCP) should be discussed alongside your topical formula.

Trying to Conceive

Pause tretinoin-containing formulas before stopping contraception. Switch to an azelaic acid or niacinamide-only formula in the interim. Discuss timing with your OB-GYN or reproductive endocrinologist.

Pregnancy

Do not use tretinoin. A formula adjusted to azelaic acid plus niacinamide is the safer option if you want to continue treating acne or pigmentation. Confirm any ongoing formula with your OB provider before continuing the subscription.

Postpartum and Breastfeeding

Azelaic acid and topical clindamycin with benzoyl peroxide are the most evidence-supported options. Restart tretinoin after weaning.

Perimenopause

Strong candidate for Agency. Tretinoin addresses collagen loss and photoaging, tranexamic acid targets the melasma and PIH that worsen with hormonal fluctuation, and azelaic acid handles both pigmentation and any rosacea that tends to emerge in this decade. The multi-active tiers (and their higher price points) are most relevant here.

Postmenopause

Agency's formulas remain useful for anti-aging maintenance. The conversation about whether systemic hormone therapy might address skin concerns at the root is worth having separately with a menopause-certified clinician, not with a telehealth skincare platform.

Agency vs. Alternatives: How the Cost Compares

| Platform | Monthly Cost | Ingredients Available | In-Person Option | |---|---|---|---| | Agency | $35 to $90 | Tretinoin, azelaic acid, TXA, niacinamide, clindamycin | No | | Curology | $30 to $60 | Tretinoin, azelaic acid, niacinamide, clindamycin | No | | Dermatologist (insurance) | $0 to $50 copay | Full formulary | Yes | | Dermatologist (self-pay) | $150 to $350 per visit | Full formulary | Yes | | Retail pharmacy (tretinoin alone, GoodRx) | $12 to $40 | Tretinoin only | No |

The comparison that matters most is Agency vs. Seeing a board-certified dermatologist in person. If your skin concern is complex (nodular acne, significant rosacea, suspected perioral dermatitis, or skin changes that could signal something other than routine acne), in-person care wins every time. Agency is a reasonable middle-ground for women with mild-to-moderate acne, early photoaging, or melasma who want clinician oversight without the access barriers of in-person dermatology.

Is Agency Legitimate? What the Evidence and Regulations Actually Say

Agency operates legally. It uses licensed clinicians, partners with legitimate compounding pharmacies, and its core prescribed ingredients have strong clinical evidence. The legitimacy question is not about legality. It is about whether you know what you are getting.

The evidence gap to flag honestly: compounded formulas are not tested as finished products. A compounding pharmacy can prepare a tretinoin 0.05% plus azelaic acid 10% plus niacinamide 4% formula, but no randomized controlled trial has tested that exact combination at those exact concentrations in a single vehicle. You are getting the ingredients that are individually well-supported, combined in ways that are clinically reasonable, without the finished-product evidence base of a single-agent FDA-approved drug. That is not unique to Agency; it applies to the entire compounded skincare category. The FDA has issued multiple warnings about unsubstantiated claims from compounding pharmacies more broadly, though Agency itself is not the subject of any current FDA enforcement action that is publicly available.

Women have been historically under-represented in dermatology trials, and trials specifically examining how tretinoin efficacy or tolerability differs across menstrual cycle phases, or across the perimenopause transition, are essentially absent from the published literature. What you see in Agency's clinical outcomes is extrapolated from general population data, not women-specific RCT evidence. That is an honest gap worth naming.

Practical Tips Before You Sign Up

• Ask which clinician type will review your intake. State licensing varies, and knowing whether you have access to a dermatologist vs. A generalist NP matters for complex cases.
• Tell them your full hormonal picture. If you have PCOS, are on hormonal contraception, are perimenopausal, or have a history of melasma in pregnancy, say so in the intake. It changes the appropriate formula.
• Set a calendar reminder 3 days before your trial ends to avoid an unwanted renewal charge.
• Do not stop your formula cold if you become pregnant. Contact the platform to pause, and call your OB-GYN the same day.
• Photograph your skin monthly under the same lighting. This is the only way to objectively assess whether a formula is working over a 12-to-16-week timeline, the minimum time tretinoin takes to show measurable benefit per the original tretinoin clinical trial data.

If you are not seeing improvement after 16 weeks at the correct concentration, escalate to a board-certified dermatologist rather than continuing to pay for a formula that is not working.